WHO collaborating centres
The WHO collaborating centres form part of an institutional collaborative network set up by WHO to support its technical work. They provide services to WHO at the country, regional and global levels, and are involved in technical cooperation for national health development. The European Region is fortunate to have seven collaborating centres dedicated to medicines.
Council of Europe
The Council collaborates with WHO/Europe through its European Directorate for the Quality of Medicines (EDQM), especially through its European Committee on Pharmaceuticals and Pharmaceutical Care, on the issues of counterfeit medicines, and quality and safety standards for pharmaceutical practices and pharmaceutical care.
European Union
WHO/Europe collaborates with the European Union through direct policy consultation and networking initiatives, including the Pharmaceutical Pricing and Reimbursement Information Network, the Pharmaceutical Health Information System Network and the Network of Competent Authorities on Pricing and Reimbursement. We also maintain regular contact and consultation with the European Medicines Agency on medicines regulation.
EuroPharm Forum
Joint network of national pharmaceutical associations and WHO/Europe
Global Fund to Fight AIDS, Tuberculosis and Malaria
International financing institution that supports large-scale projects: WHO/Europe assists countries in complying with Global Fund quality requirements for pharmaceutical products
Health Action International
Collaborates closely with WHO in the monitoring of prices in Member States and in the rational use of medicines with a special focus on regulation of promotion
Medicines Transparency Alliance
Initiative of the United Kingdom Department for International Development that brings together international institutions, governments, civil society and business to improve the health of some of the world’s most disadvantaged people
World Bank
WHO/Europe works with World Bank country offices in Member States on projects focusing on national policies, quality assurance and rational use of medicines
